Beijing, China

Qi Ji

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Beijing Forelandpharma Co. Ltd., Beone Medicines I Gmbh, Foreland Pharma Co., Ltd.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qi Ji. Retrieved from https://idiyas.com/inventor/qi-ji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0


 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Qi Ji - Revolutionizing Technology in Beijing

Introduction: Qi Ji is a pioneering inventor based in Beijing, China, known for her groundbreaking contributions to the field of technology.

Latest Patents: Qi Ji holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing her innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Qi Ji has worked with leading tech companies and research institutions to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Qi Ji has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and knowledge exchange to push the boundaries of technological advancements.

Conclusion: Qi Ji's relentless pursuit of innovation and her passion for creating a better future through technology make her a true trailblazer in the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…